HealthEquity, Inc. (NASDAQ:HQY)‘s stock had its “buy” rating reiterated by equities research analysts at Chardan Capital in a report released on Monday.
Several other equities analysts have also recently issued reports on the company. Zacks Investment Research cut HealthEquity from a “hold” rating to a “sell” rating in a research note on Monday, December 12th. KeyCorp initiated coverage on HealthEquity in a research note on Monday, January 23rd. They issued an “overweight” rating and a $60.00 price target on the stock. Finally, J P Morgan Chase & Co started coverage on HealthEquity in a research note on Friday, October 28th. They issued an “overweight” rating and a $43.00 price target on the stock. One research analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $40.20.
HealthEquity (NASDAQ:HQY) opened at 44.18 on Monday. The firm has a market cap of $2.62 billion, a P/E ratio of 105.19 and a beta of 1.94. The stock has a 50 day moving average price of $45.01 and a 200 day moving average price of $38.14. HealthEquity has a 1-year low of $18.08 and a 1-year high of $49.25.
HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, December 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.09 by $0.01. The firm earned $43.36 million during the quarter, compared to the consensus estimate of $43.29 million. HealthEquity had a return on equity of 11.08% and a net margin of 15.19%. The company’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same quarter last year, the company posted $0.08 EPS. On average, analysts anticipate that HealthEquity will post $0.42 EPS for the current year.
This report was first published by sleekmoney and is owned by of sleekmoney. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this report can be accessed at http://sleekmoney.com/healthequity-inc-hqy-rating-reiterated-by-chardan-capital/1661740.html.
In other HealthEquity news, VP Ashley Dreier sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, November 28th. The stock was sold at an average price of $43.38, for a total transaction of $216,900.00. Following the completion of the transaction, the vice president now owns 5,000 shares in the company, valued at approximately $216,900. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Darcy G. Mott sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, January 20th. The shares were sold at an average price of $47.73, for a total value of $477,300.00. Following the transaction, the vice president now owns 70,000 shares of the company’s stock, valued at approximately $3,341,100. The disclosure for this sale can be found here. Insiders have sold 1,472,352 shares of company stock valued at $65,752,723 in the last quarter. 29.00% of the stock is currently owned by company insiders.
Several large investors have recently bought and sold shares of HQY. O Shaughnessy Asset Management LLC bought a new stake in HealthEquity during the fourth quarter valued at about $108,000. Teacher Retirement System of Texas raised its stake in shares of HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock worth $184,000 after buying an additional 1,850 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of HealthEquity during the third quarter worth about $220,000. Aperio Group LLC acquired a new stake in shares of HealthEquity during the third quarter worth about $227,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in shares of HealthEquity during the third quarter worth about $231,000. 89.22% of the stock is owned by institutional investors and hedge funds.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/healthequity-inc-hqy-rating-reiterated-by-chardan-capital/1661740.html
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.